(Q24202831)

3

0 references

Sally Merry

5

object named as

Sally N Merry

0 references

author name string

Georgina R Cox

1

0 references

Patch Callahan

2

0 references

Alexandra G Parker

6

0 references

Sarah E Hetrick

Cochrane Database of Systematic Reviews

7

0 references

publication date

14 November 2012

0 references

published in

0 references

cites work

Cost-effectiveness of selective serotonin reuptake inhibitors and routine specialist care with and without cognitive behavioural therapy in adolescents with major depression

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

Treated depression in adolescents: predictors of outcome at 28 weeks

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

Clinical and psychosocial predictors of suicide attempts and nonsuicidal self-injury in the Adolescent Depression Antidepressants and Psychotherapy Trial (ADAPT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

The effects of cognitive-behavioural therapy on mood-related ruminative response style in depressed adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

Treatment of school refusal: one-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

Family dimensions in anxious-depressed school refusers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

Double-blind placebo-controlled trial of fluoxetine in adolescents with comorbid major depression and an alcohol use disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

Outcome of adolescent depression: 6 months after treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

A comparison of cognitive-behavioral therapy, sertraline, and their combination for adolescent depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

A randomized controlled trial of fluoxetine and cognitive behavioral therapy in adolescents with major depression, behavior problems, and substance use disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

Predictors and moderators of acute outcome in the Treatment for Adolescents with Depression Study (TADS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

Cost-effectiveness of treatments for adolescent depression: results from TADS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

Relative cost-effectiveness of treatments for adolescent depression: 36-week results from the TADS randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

An exploratory analysis of the impact of family functioning on treatment for depression in adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

Treating depression and oppositional behavior in adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

After TADS, can we measure up, catch up, and ante up?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

Clinical messages from the Treatment for Adolescents With Depression Study (TADS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

The Treatment for Adolescents with Depression Study (TADS): methods and message at 12 weeks

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

A manual-based intervention to address clinical crises and retain patients in the Treatment of Adolescents With Depression Study (TADS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

The Treatment for Adolescents With Depression Study (TADS): long-term effectiveness and safety outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

The Treatment of Adolescent Suicide Attempters study (TASA): predictors of suicidal events in an open treatment trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

Cognitive-behavioral therapy for suicide prevention (CBT-SP): treatment model, feasibility, and acceptability

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

Depressive symptoms and clinical status during the Treatment of Adolescent Suicide Attempters (TASA) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

Maintenance study for adolescent depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

A feasibility study of the childhood depression medication algorithm: the Texas Children's Medication Algorithm Project (CMAP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

A pilot pharmacotherapy trial for depressed youths at high genetic risk for bipolarity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

Impact of multifamily psychoeducational psychotherapy in treating children aged 8 to 12 years with mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

The Youth-Nominated Support Team-Version II for suicidal adolescents: A randomized controlled intervention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

Randomized study of school-based intensive interpersonal psychotherapy for depressed adolescents with suicidal risk and parasuicide behaviors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

The treatment of SSRI-resistant depression in adolescents (TORDIA): in search of the best next step

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

Predictors of spontaneous and systematically assessed suicidal adverse events in the treatment of SSRI-resistant depression in adolescents (TORDIA) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

Treatment of Resistant Depression in Adolescents (TORDIA): week 24 outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

Effective components of TORDIA cognitive-behavioral therapy for adolescent depression: preliminary findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

Cognitive-behavioral therapy to prevent relapse in pediatric responders to pharmacotherapy for major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: two randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

Practice parameter for the assessment and treatment of children and adolescents with depressive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

Assessment of suicidal intention: The Scale for Suicide Ideation

21 January 2018

2 references

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

21 January 2018

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

7 January 2021

Childhood and adolescent depression: a review of the past 10 years. Part I.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

Psychological interventions for major depression in primary care: a meta-analytic review of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

A clinical psychotherapy trial for adolescent depression comparing cognitive, family, and supportive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

Diagnosis and measurement of adolescent depression: a review of commonly utilized instruments

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

The assessment of affective disorders in children and adolescents by semistructured interview. Test-retest reliability of the schedule for affective disorders and schizophrenia for school-age children, present episode version

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

Expert survey for the management of adolescent depression in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

Relative efficacy of psychotherapy and combined therapy in the treatment of depression: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

Combined treatment with cognitive-behavioural therapy in adolescent depression: meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

Continuation and maintenance therapy of early-onset major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

Selective serotonin reuptake inhibitors (SSRIs) and routine specialist care with and without cognitive behaviour therapy in adolescents with major depression: randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

Forum: the use of selective serotonin reuptake inhibitors in depressed children and adolescents: commentary on the meta-analysis by Hetrick et al.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

Psychopathology associated with suicidal ideation and attempts among children and adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

Brief scale for measuring the outcomes of emotional and behavioural disorders in children. Health of the Nation Outcome Scales for children and Adolescents (HoNOSCA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

A rating scale for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

Suicidality in pediatric patients treated with antidepressant drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

Tricyclic drugs for depression in children and adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

The use of SSRIs in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

Treatment-resistant depression in adolescents: is the addition of cognitive behavioral therapy of benefit?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

A psychometric evaluation of the CDRS and MADRS in assessing depressive symptoms in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

Recovery in major depressive disorder: analysis with the life table and regression models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

A theoretical framework for nondirective play therapy: Concepts from psychoanalysis and learning theory

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

Major depressive disorder in older adolescents: prevalence, risk factors, and clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

The Multidimensional Anxiety Scale for Children (MASC): factor structure, reliability, and validity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

A New Depression Scale Designed to be Sensitive to Change

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

Efficacy of interpersonal psychotherapy for depressed adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

A randomized effectiveness trial of interpersonal psychotherapy for depressed adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

Ten-year review of rating scales. II: Scales for internalizing disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

Combined pharmacotherapy and psychological treatment for depression: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

Efficacy of antidepressants in child and adolescent depression: a meta-analytic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

The CES-D Scale: A Self-Report Depression Scale for Research in the General Population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

What I think and feel: a revised measure of children's manifest anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

An efficacy/effectiveness study of cognitive-behavioral treatment for adolescents with comorbid major depression and conduct disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

Computerised cognitive behavioural therapy for the prevention and treatment of depression and anxiety in children and adolescents: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

The treatment of adolescent depression in the era of the black box warning

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

A children's global assessment scale (CGAS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

A comparison of the relative efficacy of self-control therapy and a behavioral problem-solving therapy for depression in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

The Self-Efficacy Questionnaire for Depression in Adolescents (SEQ-DA). Development and psychometric evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

Efficacy of antidepressants in juvenile depression: meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

Psychotherapy for depression in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

Psychotherapy for depression among children and adolescents: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

Children's symptom and social functioning self-report scales. Comparison of mothers' and children's reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

Treatment options in the management of adolescent depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

Guidelines for Adolescent Depression in Primary Care (GLAD-PC): I. Identification, assessment, and initial management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

NIMH's TADS: More than just a tad of progress?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

A double-blind, placebo-controlled trial of sertraline in depressed adolescent alcoholics: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

7 January 2021

Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

7 January 2021

Anxiety Rating for Children — Revised: Reliability and validity

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

7 January 2021

Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents with Depression Study (TADS) randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

7 January 2021

A randomized effectiveness trial of brief cognitive-behavioral therapy for depressed adolescents receiving antidepressant medication

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

7 January 2021

The Cognitive Therapy Scale: psychometric properties

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

7 January 2021

Brief treatment of mild-to-moderate child depression using primary and secondary control enhancement training

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

7 January 2021

Cognitive bibliotherapy for mild and moderate adolescent depressive symptomatology

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

7 January 2021

Cognitive-behavioral treatment of school phobia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

7 January 2021

Imipramine plus cognitive-behavioral therapy in the treatment of school refusal

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

7 January 2021

Imipramine compliance in adolescents

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

7 January 2021

Predictors of treatment response in anxious-depressed adolescents with school refusal

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

7 January 2021

Glad for what TADS adds, but many TADS grads still sad

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

7 January 2021

Acute time to response in the Treatment for Adolescents with Depression Study (TADS)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

7 January 2021

Reliability of a Timeline Method: assessing normal drinkers' reports of recent drinking and a comparative evaluation across several populations

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

7 January 2021

CBT plus an SSRI was as effective as an SSRI alone for adolescents with moderate to severe depression

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

7 January 2021

Reliability and validity of DSM-IV axis V

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

7 January 2021

Suicidal behaviour in youths with depression treated with new-generation antidepressants: meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

7 January 2021

Perceived parental burden and service use for child and adolescent psychiatric disorders

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008324.PUB2

7 January 2021

10.1002/14651858.CD008324.PUB2

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

release_pwienryu65d2hf222eexrrpdfq

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/pwienryu65d2hf222eexrrpdfq

24 November 2022

mapped directly with Wikidata item

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

23152255

1 reference

Consolidated OpenCitations Corpus – April 2017